Work

Adjuvant therapy in resected non-small cell lung cancer: current status and perspectives

Year: 2025

Type: article

Abstract: Adjuvant chemotherapy increases overall survival of patients with completely resected non-small cell lung cancer. Adjuvant therapy with immune checkpoint inhibitors and tyrosine kinase inhibitors have further improved outcome in selected patients. These therapeutic achievements are discussed in the present commentary.

Source: Holistic Integrative Oncology

DOI: 10.1007/s44178-024-00136-2

Author: Robert Pirker

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4408535760

FWCI: 3.038

Cites: 31

Cited by: 5

Related to: 10